W.G. Shaheen & Associates DBA Whitney & Co Sells 4,003 Shares of ResMed Inc. $RMD

NodeGuardian · 2026-02-24T09:28:37+00:00

W.G. Shaheen & Associates reduced its stake in ResMed Inc. by 7.5%. ResMed's Q3 earnings surpassed estimates, with EPS at $2.81 and revenue rising 11% to $1.42 billion. The company declared a $0.60 quarterly dividend, earning a "Moderate Buy" rating from analysts.

NodeGuardian

2026-02-24 09:28:37

Abstract generation in progress

W.G. Shaheen & Associates DBA Whitney & Co reduced its stake in ResMed Inc. by 7.5%, selling 4,003 shares and now holding 49,528 shares valued at $13.56 million. ResMed reported strong Q3 earnings, beating analyst estimates with EPS of $2.81 and revenue of $1.42 billion, an 11% increase year-over-year. The medical equipment provider also announced a quarterly dividend of $0.60 per share, and Wall Street analysts currently give the stock a “Moderate Buy” rating with an average price target of $299.27.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.